2.51
0.04 (1.62%)
0.04 (1.62%)
Upgrade to Real-Time
Regular Market
Low
2.09
High
12.48
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Akebia Therapeutics Inc | AKBA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.04 | 1.62% | 2.51 | 13:41:10 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.48 | 2.43 | 2.56 | 2.47 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.50 | 2.51 | 0.01 | - | 1 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,864 | 3,372,796 | $ 2.48 | $ 8,371,975 | - | 2.09 - 12.48 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:42:47 | 48 | $ 2.51 | USD |
Period:
Draw Mode:
Akebia Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 401.89M | 160.12M | 136.06M | $ 295.31M | $ - | -2.76 | -0.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 189.03k | 2.00% |
Akebia Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AKBA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.03 | 3.04 | 2.43 | 2.66 | 8,823,279 | -0.52 | -17.16% |
| 1 Month | 4.25 | 4.33 | 2.43 | 3.06 | 4,567,973 | -1.74 | -40.94% |
| 3 Months | 3.23 | 4.33 | 2.43 | 3.34 | 3,989,215 | -0.72 | -22.29% |
| 6 Months | 3.81 | 5.14 | 2.43 | 3.58 | 4,866,061 | -1.30 | -34.12% |
| 1 Year | 11.82 | 12.48 | 2.09 | 3.35 | 5,530,001 | -9.31 | -78.76% |
| 3 Years | 10.66 | 13.78 | 2.09 | 4.56 | 2,594,216 | -8.15 | -76.45% |
| 5 Years | 8.55 | 20.25 | 2.09 | 5.32 | 1,725,200 | -6.04 | -70.64% |
Akebia Therapeutics Description
| Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States. |
